Skip to content

Clinical trials

Expanded access Glioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Expanded access Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available7
Approved for marketing3
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals3
Center Trials & Treatment2
Blueprint Medicines Corporation1
Day One Biopharmaceuticals, Inc.1
Genexine, Inc.1
Servier1
Telix Pharmaceuticals (Innovations) Pty Limited1
Zentrum fur Humangenetik Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma11
Glioblastoma3
Melanoma2
Neoplasms2
Astrocytoma1
Disease Attributes1
Gastrointestinal Stromal Tumors1
Neoplasms by Histologic Type1
Neoplasms, Germ Cell and Embryonal1
Neoplasms, Glandular and Epithelial1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.